Agios Pharmaceuticals, Inc. (AGIO) Institutional Ownership

Ownership Summary

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) currently has 220 active institutional owners and shareholders as of today (September 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• The percentage of Agios Pharmaceuticals owned by institutions changed from 105.1% in June 2025 to 110.5% in September 2025, marking a slight up trend.
• Quarterly data indicates a 4.55% shift in institutional share volume, and the annual owner count reflects an increase of 6.80%.
• During the quarter, 99 institutions bought more Agios Pharmaceuticals shares, 83 sold shares, and 38 of the 220 total investors held their position steady.
• Collectively, institutional investors increased their stake in Agios Pharmaceuticals to 64.21Mn shares as of September 2025, a change that is up by 2.80Mn shares quarter on quarter and up 5.72Mn shares year over year.
• The top institutional stake in Agios Pharmaceuticals as of September 30, 2025 belongs to FARALLON CAPITAL MANAGEMENT LLC, which owns 5.78Mn shares, or 9.95% of the company.
• Among the most significant buyers of Agios Pharmaceuticals during September 2025 were WELLINGTON MANAGEMENT GROUP LLP (2.05Mn), Paradigm Biocapital Advisors LP (1.53Mn), TCG Crossover Management, LLC (733.04K), Erste Asset Management GmbH (438.41K), JANE STREET GROUP, LLC (429.63K).
• Leading sellers of Agios Pharmaceuticals stock in September 2025 included JPMORGAN CHASE & CO (844.32K), Vestal Point Capital, LP (633.00K), PRICE T ROWE ASSOCIATES INC /MD/ (617.31K), MARSHALL WACE, LLP (457.85K), ARMISTICE CAPITAL, LLC (404.00K).
• The top 10 institutional holders of Agios Pharmaceuticals for the quarter ending September 2025 included FARALLON CAPITAL MANAGEMENT LLC (5.78Mn), VANGUARD GROUP INC (5.60Mn), BlackRock, Inc. (4.55Mn), Bellevue Group AG (3.71Mn), Erste Asset Management GmbH (2.76Mn), Paradigm Biocapital Advisors LP (2.67Mn), WELLINGTON MANAGEMENT GROUP LLP (2.47Mn), Commodore Capital LP (2.34Mn), STATE STREET CORP (2.26Mn), MACQUARIE GROUP LTD (1.96Mn).